Related Experiment Video
Updated: May 17, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Therapeutic potential of thymosin β4 in myocardial infarct and heart failure
Christoffer Stark1, Pekka Taimen, Miikka Tarkia
1Department of Surgery, Turku University Central Hospital, Turku, Finland. christoffer.stark@utu.fi
Abstract:
Thymosin β4 (Tβ4) is a peptide known for its abilities to protect and facilitate regeneration in a number of tissues following injury. Its cardioprotective effects have been evaluated in different animal models and, currently, a clinical trial is being planned in patients suffering from acute myocardial infarction. This paper focuses on the effects of Tβ4 on cardiac function in animal studies utilizing different imaging modalities for outcome measurements.
Related Concept Videos
Myocarditis III: Medical Management
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: β-Blockers
Myocarditis IV: Nursing Management
Pathophysiology of Heart Failure
Myocarditis I: Introduction
